Cancer Center Claims Drug Cos. 'Robbed' It Of IP Revenue
Boston-based Dana-Farber Cancer Institute says it should get a cut of more than $1.6 billion in licensing revenue Bristol-Myers Squibb Co. and Ono Pharmaceutical Co. Ltd. have raked in from immunology...To view the full article, register now.
Already a subscriber? Click here to view full article